Has Arlen Halstead received payments from drug or device companies?

Yes. Drug and device makers reported $3,224 in general payments to Arlen Halstead across 156 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arlen Halstead did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arlen Halstead come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arlen Halstead

Psychiatric/Mental Health · Syracuse, NYNPI 1861798977

Payments from drug & device makers

$3,224in general payments, 2019–2025

Across 156 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$877
Teva Pharmaceuticals USA, Inc.$430
Indivior Inc.$384
Alkermes, Inc.$313
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$244
Otsuka America Pharmaceutical, Inc.$217
plus $760 from 10 others

What the payments were for

Food & beverage$3,15398%
Education$712%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	44	$877
Teva Pharmaceuticals USA, Inc.	17	$430
Indivior Inc.	22	$384
Alkermes, Inc.	12	$313
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$244
Otsuka America Pharmaceutical, Inc.	10	$217
Johnson & Johnson	9	$177
E.r. Squibb & Sons, L.L.C.	7	$139
Lundbeck LLC	6	$115
Vanda Pharmaceuticals Inc.	3	$101
Corium, LLC	3	$51
Neurocrine Biosciences, Inc.	3	$51
Axsome Therapeutics, Inc.	2	$50
Orexo US, Inc.	3	$47
Braeburn Inc.	1	$16
Gilead	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,224 in reported general payments places this provider in the 85th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	21	$62,798
Olanzapine	63	$1,998
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	20	$1,651
Aripiprazole	19	$1,581
Clozapine	29	$1,210
Atomoxetine Hcl	17	$958
Prazosin Hcl	34	$718
Fluoxetine Hcl	24	$530
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	16	$450
Lurasidone Hcl	17	$380
Sertraline Hcl	66	$311
Venlafaxine Hcl ErVenlafaxine Hcl	27	$264
Trazodone Hcl	48	$206
Clonidine Hcl	25	$181
Lamotrigine	38	$167

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$177	$62,79821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

Sherie RamsgardSyracuse$52K
Laneasha EudellSyracuse$15K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →